Literature DB >> 22562517

Positioning of electronic subretinal implants in blind retinitis pigmentosa patients through multimodal assessment of retinal structures.

Akos Kusnyerik1, Udo Greppmaier, Robert Wilke, Florian Gekeler, Barbara Wilhelm, Helmut G Sachs, Karl Ulrich Bartz-Schmidt, Uwe Klose, Katarina Stingl, Miklos D Resch, Anusch Hekmat, Anna Bruckmann, Kristof Karacs, Janos Nemeth, Ildiko Suveges, Eberhart Zrenner.   

Abstract

PURPOSE: To optimize methods for positioning subretinal visual implants, customizing their cable length, guiding them to the predetermined retinal position, and evaluating their performance.
METHODS: Ten eyes of 10 patients (6 male, 4 female, mean age 46.4 years) were investigated before implantation of a subretinal visual implant. The structural characteristics of the retina as well as the ocular dimensions were determined. Topographic images of the prospective implantation site were subdivided into grids of squares. Each square received a weighted score for suitability. The sum of the scores was calculated, and the region with the highest score was chosen for the implant. In each case, the implant's power supply cable length was calculated by means of magnetic resonance imaging. The planned and achieved positions before and after implantation were compared.
RESULTS: The mean light sensitivity ratio between the area actually covered by the chip and that of the planned position was 90.8% with an SD of 11.4%. In two cases with almost perfect positioning, the computed ratio was 100%. Measurements showed that to achieve a 95% sensitivity rate the difference between the planned and achieved chip position must be less than 1.7 mm. Preoperative calculations of the intraocular cable length proved accurate in all cases.
CONCLUSIONS: Preoperative evaluation of retinal structures and eye morphology is useful for guiding a retinal implant to the designated area. It is a meaningful tool for planning and performing retinal chip implantation, and it optimizes personalized implantation. (ClinicalTrials.gov numbers, NCT00515814, NCT01024803.).

Entities:  

Mesh:

Year:  2012        PMID: 22562517     DOI: 10.1167/iovs.11-9409

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  The influence of axial length on confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography size measurements: a pilot study.

Authors:  T Röck; B Wilhelm; K U Bartz-Schmidt; D Röck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-23       Impact factor: 3.117

2.  Safety evaluation of "retina implant alpha IMS"--a prospective clinical trial.

Authors:  Veronique B D Kitiratschky; Katarina Stingl; Barbara Wilhelm; Tobias Peters; Dorothea Besch; Helmut Sachs; Florian Gekeler; Karl Ulrich Bartz-Schmidt; Eberhart Zrenner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-16       Impact factor: 3.117

3.  Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS.

Authors:  Katarina Stingl; Karl Ulrich Bartz-Schmidt; Dorothea Besch; Angelika Braun; Anna Bruckmann; Florian Gekeler; Udo Greppmaier; Stephanie Hipp; Gernot Hörtdörfer; Christoph Kernstock; Assen Koitschev; Akos Kusnyerik; Helmut Sachs; Andreas Schatz; Krunoslav T Stingl; Tobias Peters; Barbara Wilhelm; Eberhart Zrenner
Journal:  Proc Biol Sci       Date:  2013-02-20       Impact factor: 5.349

4.  Targeting inflammation in emerging therapies for genetic retinal disease.

Authors:  Ishaq A Viringipurampeer; Abu E Bashar; Cheryl Y Gregory-Evans; Orson L Moritz; Kevin Gregory-Evans
Journal:  Int J Inflam       Date:  2013-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.